- A Study of Antihypertensive Effect of Isradipine(Dynacirc)
-
Kim HS, Cho JH, Kwon SO
- KMID: 2093365
- Korean Circ J.
- 1992 Feb;22(1):146-150.
- doi: 10.4070/kcj.1992.22.1.146
Essential hypertension is an important public health problem in Korea-being common, asymptomatic, easily treatable, and often leading to lethal complication in left untreated. The number of patients with hypertension has... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Efficacy and Tolerability of Isradipine in the Treatment of Mild to Moderate Hypertension
-
Lee DI, Shin JA, Moon CH, Lee JY, Cha KS, Shin YW, Shin YK
- KMID: 2229166
- Korean Circ J.
- 1991 Aug;21(4):757-763.
- doi: 10.4070/kcj.1991.21.4.757
An open clinical trial was conducted to evaluate the efficacy and tolerability of isradipine in 30 cases (male 16, female 14 cases, average age 52.6+/-7.94) of mild to moderate essential... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of gingival hyperplasia caused by felodipine
-
Park JS, Lee CH, Kim NR, No DH, Kim DH, Choi SY, Jeong JH
- KMID: 2081662
- Korean J Med.
- 2009 Apr;76(Suppl 1):S93-S96.
Felodipine is a calcium channel blocker that is used in the management of hypertension. Calcium channel blockers, along with phenytoin and cyclosporin, are implicated as a cause of gingival hyperplasia.... -
- CITED
-
- Close
- SHARE
-
- Close
- Antihypertensive Effects and Safety of Isradipine in Patients with Essential Hypertension
-
Cheong HJ, Kang HS, Choue CW, Kim KS, Kim MS, Song JS, Bae JH, Lee CK, Kim HS, Kwon KI, Shin SY
- KMID: 2229257
- Korean Circ J.
- 1993 Oct;23(5):741-749.
- doi: 10.4070/kcj.1993.23.5.741
BACKGROUND: Antihypertensive treatment represents the modification of one of the most important risk factors on the development of cardiovascular, cerebrovascular and peripheral vascular disease. In cases of markedly developed atherosclerosis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization
-
Lee HA, Hyun SA, Park SG, Kim KS, Kim SJ
- KMID: 2150481
- Korean J Physiol Pharmacol.
- 2016 Jan;20(1):119-127.
- doi: 10.4196/kjpp.2016.20.1.119
Dihydropyridine (DHP) calcium channel blockers (CCBs) have been widely used to treat of several cardiovascular diseases. An excessive shortening of action potential duration (APD) due to the reduction of Ca2+... -
- CITED
-
- Close
- SHARE
-
- Close
